Literature DB >> 8271524

Effects of semotiadil fumarate, a novel calcium antagonist, on blood pressure and heart rate in conscious spontaneously hypertensive rats.

A Kanda1, H Hashimoto.   

Abstract

The acute antihypertensive effects of orally administered semotiadil, a novel calcium antagonist, were compared with those of nifedipine and diltiazem in conscious, unrestrained spontaneously hypertensive rats (SHRs). Semotiadil (10 and 30 mg/kg) produced a dose-dependent hypotension that persisted for 18 hr at 30 mg/kg. Diltiazem (30 and 100 mg/kg) and nifedipine (1 and 3 mg/kg) also exhibited hypotension dose-dependently, but their durations of actions were shorter than that of semotiadil. Semotiadil caused a slight increase in heart rate, while diltiazem and nifedipine caused a bradycardia and a marked tachycardia, respectively. These results suggest that semotiadil has a beneficial property as an antihypertensive drug.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8271524     DOI: 10.1254/jjp.63.121

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  2 in total

1.  Pharmacological profile of semotiadil fumarate, a novel calcium antagonist, in rat experimental angina model.

Authors:  T Mori; Y Ishigai; A Fukuzawa; K Chiba; T Shibano
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

2.  Insufficient fumarase contributes to hypertension by an imbalance of redox metabolism in Dahl salt-sensitive rats.

Authors:  Xuewei Zheng; Meng Chen; Xiaoxue Li; Pengfei Yang; Xinrui Zhao; Yanan Ouyang; Zhe Yang; Mingyu Liang; Entai Hou; Zhongmin Tian
Journal:  Hypertens Res       Date:  2019-06-24       Impact factor: 3.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.